JP2009524807A - 抗トロポニン抗体および心臓血管リスク - Google Patents

抗トロポニン抗体および心臓血管リスク Download PDF

Info

Publication number
JP2009524807A
JP2009524807A JP2008551711A JP2008551711A JP2009524807A JP 2009524807 A JP2009524807 A JP 2009524807A JP 2008551711 A JP2008551711 A JP 2008551711A JP 2008551711 A JP2008551711 A JP 2008551711A JP 2009524807 A JP2009524807 A JP 2009524807A
Authority
JP
Japan
Prior art keywords
cardiac troponin
risk
troponin
individual
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008551711A
Other languages
English (en)
Japanese (ja)
Inventor
ハレルマイヤー，クラウス
カートゥス，フーゴ
カーヤ，ツィーヤ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/340,012 external-priority patent/US20070172888A1/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2009524807A publication Critical patent/JP2009524807A/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2008551711A 2006-01-25 2007-01-23 抗トロポニン抗体および心臓血管リスク Pending JP2009524807A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/340,012 US20070172888A1 (en) 2006-01-25 2006-01-25 Measuring troponin antibodies to assess cardiovascular risk
EP06001483 2006-01-25
PCT/EP2007/000537 WO2007085411A1 (fr) 2006-01-25 2007-01-23 Anticorps anti-troponine et risque cardiovasculaire

Publications (1)

Publication Number Publication Date
JP2009524807A true JP2009524807A (ja) 2009-07-02

Family

ID=37749974

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008551711A Pending JP2009524807A (ja) 2006-01-25 2007-01-23 抗トロポニン抗体および心臓血管リスク

Country Status (4)

Country Link
EP (1) EP1979748A1 (fr)
JP (1) JP2009524807A (fr)
CA (1) CA2637253A1 (fr)
WO (1) WO2007085411A1 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011206049A (ja) * 2010-03-08 2011-10-20 Sumio Sugano 壊死マーカー及びその用途
JP2013508687A (ja) * 2009-10-15 2013-03-07 クレッシェンド バイオサイエンス インコーポレイテッド 炎症性疾患活動性を測定およびモニタリングするためのバイオマーカーおよび方法
JP2017500547A (ja) * 2013-11-15 2017-01-05 オタゴ イノベーション リミテッド 心臓障害のためのバイオマーカー
WO2017033846A1 (fr) * 2015-08-21 2017-03-02 扶桑薬品工業株式会社 Procédé d'analyse immunologique et kit d'analyse immunologique
US10718765B2 (en) 2014-04-02 2020-07-21 Crescendo Bioscience, Inc. Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity
US10983120B2 (en) 2015-09-29 2021-04-20 Crescendo Bioscience Methods for assessing response to inflammatory disease therapy withdrawal
US11174310B2 (en) 2016-10-26 2021-11-16 Fuso Pharmaceutical Industries, Ltd. Disulfide-type HMGB1-specific antibody, method for measuring disulfide-type HMGB1 and kit for said measurement, and measurement method capable of quantitating all of HMGB1 molecules including reduced HMGB1, disulfide-type HMGB1 and thrombin-cleavable HMGB1 and kit for said measurement
US11493512B2 (en) 2014-06-10 2022-11-08 Laboratory Corporation Of America Holdings Biomarkers and methods for measuring and monitoring axial spondyloarthritis activity
US11656227B2 (en) 2015-09-29 2023-05-23 Crescendo Bioscience Biomarkers and methods for assessing psoriatic arthritis disease activity

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5057402B2 (ja) 2006-10-26 2012-10-24 アボット・ラボラトリーズ 内在性の抗分析物抗体を含有する試料中の分析物の免疫アッセイ
US7776605B2 (en) 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
EP2115466A4 (fr) * 2006-12-22 2010-07-28 Abbott Lab Panel de maladies auto-immunes cardiovasculaires et methodes d'utilisation correspondantes
CN102803965A (zh) * 2009-05-05 2012-11-28 耶达研究与发展有限公司 用于识别个人心血管疾病的发生的装置和方法
JP5683253B2 (ja) * 2010-12-21 2015-03-11 晃生 佐野 未病判定方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004037455A (ja) * 2002-05-14 2004-02-05 F Hoffmann La Roche Ag マーカーの組み合わせを用いた心臓疾患症例の予後判定

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004037455A (ja) * 2002-05-14 2004-02-05 F Hoffmann La Roche Ag マーカーの組み合わせを用いた心臓疾患症例の予後判定

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
岡崎 他１名, 医学のあゆみ, vol. 208, no. 11, JPN6011022138, 2004, pages 944 - 945, ISSN: 0001909111 *

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11300575B2 (en) 2009-10-15 2022-04-12 Laboratory Corporation Of America Holdings Biomarkers and methods for measuring and monitoring inflammatory disease activity
JP2013508687A (ja) * 2009-10-15 2013-03-07 クレッシェンド バイオサイエンス インコーポレイテッド 炎症性疾患活動性を測定およびモニタリングするためのバイオマーカーおよび方法
US9200324B2 (en) 2009-10-15 2015-12-01 Crescendo Bioscience Biomarkers and methods for measuring and monitoring inflammatory disease activity
JP2015042641A (ja) * 2010-03-08 2015-03-05 富士フイルム株式会社 壊死マーカー及びその用途
US9164096B2 (en) 2010-03-08 2015-10-20 Fujifilm Corporation Monoclonal antibody against necrosis marker PRDX4 and use thereof
JP5796008B2 (ja) * 2010-03-08 2015-10-21 富士フイルム株式会社 壊死マーカーＥＲｐ２９に対するモノクローナル抗体及びその用途
US9377461B2 (en) 2010-03-08 2016-06-28 Fujifilm Corporation Monoclonal antibody against necrosis marker ERP29 and use thereof
JP2011206049A (ja) * 2010-03-08 2011-10-20 Sumio Sugano 壊死マーカー及びその用途
US10145849B2 (en) 2010-03-08 2018-12-04 Fujifilm Corporation Monoclonal antibody against necrosis marker PRDX4 and use thereof
JP2017500547A (ja) * 2013-11-15 2017-01-05 オタゴ イノベーション リミテッド 心臓障害のためのバイオマーカー
US10718765B2 (en) 2014-04-02 2020-07-21 Crescendo Bioscience, Inc. Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity
US11493512B2 (en) 2014-06-10 2022-11-08 Laboratory Corporation Of America Holdings Biomarkers and methods for measuring and monitoring axial spondyloarthritis activity
WO2017033846A1 (fr) * 2015-08-21 2017-03-02 扶桑薬品工業株式会社 Procédé d'analyse immunologique et kit d'analyse immunologique
JPWO2017033846A1 (ja) * 2015-08-21 2018-06-07 扶桑薬品工業株式会社 免疫試験方法および免疫試験キット
US10983120B2 (en) 2015-09-29 2021-04-20 Crescendo Bioscience Methods for assessing response to inflammatory disease therapy withdrawal
US11656227B2 (en) 2015-09-29 2023-05-23 Crescendo Bioscience Biomarkers and methods for assessing psoriatic arthritis disease activity
US11174310B2 (en) 2016-10-26 2021-11-16 Fuso Pharmaceutical Industries, Ltd. Disulfide-type HMGB1-specific antibody, method for measuring disulfide-type HMGB1 and kit for said measurement, and measurement method capable of quantitating all of HMGB1 molecules including reduced HMGB1, disulfide-type HMGB1 and thrombin-cleavable HMGB1 and kit for said measurement

Also Published As

Publication number Publication date
EP1979748A1 (fr) 2008-10-15
CA2637253A1 (fr) 2007-08-02
WO2007085411A1 (fr) 2007-08-02

Similar Documents

Publication Publication Date Title
US20070172888A1 (en) Measuring troponin antibodies to assess cardiovascular risk
JP2009524807A (ja) 抗トロポニン抗体および心臓血管リスク
JP4343866B2 (ja) 容量過負荷の結果として心血管合併症に罹患するリスクを評価するための心臓ホルモンの使用
JP6654668B2 (ja) 発作性心房細動のｂｎｐ型ペプチドに基づく診断をするためのデータを提供する方法
JP4870686B2 (ja) 抗炎症剤の投与に関連する心血管リスクを評価するための心臓ホルモンの使用
ES2305541T3 (es) Scd40l, papp-a y factor de crecimiento placentario (pigf) como combinaciones de marcadores bioquimicos en enfermedades cardiovasculares.
JP4828550B2 (ja) 心機能障害を診断するためのＮＴ−ｐｒｏＡＮＰ／ＮＴ−ｐｒｏＢＮＰ比の使用
US20060286681A1 (en) Proximal markers of arterial thrombosis and inflammation for risk stratification of coronary heart disease
US20060166303A1 (en) Use of cardiac hormones for assessing a cardiovascular risk with respect to the administration of anti-inflammatory drugs
US20090155827A1 (en) PIGF and FLT-1 as Prognostic Parameters for Cardiovascular Diseases
CA2756120C (fr) Utilisation d'endostatine en tant que marqueur d'insuffisance cardiaque
EP3279665A1 (fr) Circulation d'esm-1 (endocan) dans l'évaluation de la fibrillation auriculaire
WO2009047283A2 (fr) Moyens et procédés de surveillance de l'infarctus du myocarde et son traitement
US20210190801A1 (en) Circulating bmp10 (bone morphogenic protein 10) in the assessment of atrial fibrillation
JP2019526041A (ja) 心房細動の再発の予測のための循環アンジオポエチン−２（Ａｎｇ−２）
JP5715641B2 (ja) 急性胸痛を伴い、心筋梗塞を伴わない患者において、心虚血を診断およびモニターするための方法
US11946938B2 (en) Circulating Angiopoietin-2 (Ang-2) and insulin-like growth factor-binding protein 7 (IGFBP7) for the prediction of stroke
CN101371144A (zh) 抗肌钙蛋白抗体和心血管风险
EP2103943A1 (fr) GDF-15 pour évaluer un risque cardiovasculaire en respectant l'administration des médicaments anti-inflammatoires
EP3830583A1 (fr) Dkk3 (protéine 3 associée à dickkopf) circulante dans l'évaluation de la fibrillation auriculaire
EP2133696A1 (fr) Concentrations très faibles de troponine I ou T pour évaluer un risque cardiovasculaire en fonction de l'administration de médicaments anti-inflammatoires
EP1691200A1 (fr) L'utilisation des peptides de type BNP et ANP pour évaluer les risques des complications cardiovasculaires dues a une surcharge de volume

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090818

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110502

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110428

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111013